Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) EBITDA Margin (2020 - 2025)

Sight Sciences has reported EBITDA Margin over the past 6 years, most recently at 18.0% for Q4 2025.

  • Quarterly results put EBITDA Margin at 18.0% for Q4 2025, up 4454.0% from a year ago — trailing twelve months through Dec 2025 was 47.96% (up 1532.0% YoY), and the annual figure for FY2025 was 47.95%, up 1532.0%.
  • EBITDA Margin for Q4 2025 was 18.0% at Sight Sciences, up from 39.71% in the prior quarter.
  • Over the last five years, EBITDA Margin for SGHT hit a ceiling of 18.0% in Q4 2025 and a floor of 149.14% in Q1 2022.
  • Median EBITDA Margin over the past 5 years was 77.79% (2024), compared with a mean of 82.36%.
  • Biggest five-year swings in EBITDA Margin: soared 13123bps in 2021 and later tumbled -4435bps in 2022.
  • Sight Sciences' EBITDA Margin stood at 100.21% in 2021, then increased by 17bps to 83.01% in 2022, then grew by 29bps to 59.25% in 2023, then dropped by -6bps to 62.54% in 2024, then skyrocketed by 71bps to 18.0% in 2025.
  • The last three reported values for EBITDA Margin were 18.0% (Q4 2025), 39.71% (Q3 2025), and 59.64% (Q2 2025) per Business Quant data.